NovoLabs
PrivateLast Round
Debt
Jun 19, 2025
Est. Valuation
$8.65M
Total Funding Raised
$605,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NovoLabs operates in Energy & Sustainability and is based in Palmerston North. Its latest recorded funding round was a Series A round in February 2024.
NovoLabs is a commercial products company that manufactures a patented Supercritical UV™ disinfection system for the effective treatment of process liquids and wastewaters.
Sector
Energy & Sustainability
Verticals
Water Treatment, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoLabs Comparables
Compare NovoLabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Van Remmen UV Technology | 78% | |
| Atlantium Technologies | 76% | |
| ULTRAAQUA | 73% |
For institutional investors. Book with your work email.
NovoLabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 19, 2025 | ||||
| Series A | Feb 5, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NovoLabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 2040 Ventures | Series A |
| Creative Destruction Lab | Series A, Accelerator |
| Massey Ventures | Series A, Accelerator |
| Kānoa – Regional Economic Development & Investment Unit | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 33% to 4.3K.
- Feb 5, 2024
$605K round led by 2040 Ventures and climatevcfund.
For institutional investors. Book with your work email.
NovoLabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NovoLabs's valuation, stock price, and market status.
Is NovoLabs a public or private company?
NovoLabs is a private company.
What is the current stock price of NovoLabs?
NovoLabs is a private company, so its shares have no public market price. Caplight tracks NovoLabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NovoLabs worth (valuation)?
NovoLabs's valuation is estimated at $8.6M based on funding round data.
Can I buy NovoLabs stock?
NovoLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NovoLabs's last funding round?
NovoLabs's most recent funding round was Debt on June 19, 2025.
Who are the main investors in NovoLabs?
Key investors in NovoLabs include 2040 Ventures, Creative Destruction Lab, Massey Ventures, Kānoa – Regional Economic Development & Investment Unit.
Will NovoLabs IPO soon?
No public IPO plans have been announced for NovoLabs.
How can I track NovoLabs secondary market activity?
Caplight tracks bids, offers, and trades in NovoLabs's shares on secondary markets.